FDA Inspection
Profounda IncProfounda Inc – FDA Inspection, Aug 9, 2022
Record Details
This FDA Inspection record concerns Profounda Inc, with an inspection on August 9, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Profounda Inc
- Inspection Date
- August 9, 2022
- Product Type
- Drugs
View Company Profile
ID · d94f9294-ee9c-4f00-9931-17eadfcbf47b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1177190
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.166(a)Results not used for expiration dates, storage cond.
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Profounda Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 30, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Profounda Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.